Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T)

被引:34
作者
Bell, F [1 ]
Heath, P
Shackley, F
MacLennan, J
Shearstone, N
Diggle, L
Griffiths, H
Moxon, ER
Finn, A
机构
[1] Univ Sheffield, Childrens Hosp, Dept Paediat, Sheffield Inst Vaccine Studies, Sheffield S10 2TH, S Yorkshire, England
[2] John Radcliffe Hosp, Oxford Vaccine Grp, Oxford OX3 9DU, England
[3] Churchill Hosp, Dept Immunol, Oxford OX3 7LJ, England
关键词
acellular pertussis vaccine; Hib vaccine; combination vaccine;
D O I
10.1016/S0264-410X(97)84511-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acellular pertussis vaccines provide protection against whooping cough with few adverse effects, Their introduction to routine immunisation programmes would be facilitated by their incorporation with other routinely administered vaccines. 262 infants were immunised with an acellular pertussis vaccine containing pertussis toxin and filamentous haemagglutinin, combined with diphtheria and tetanus toxoids. This vaccine was mixed with Haemophilus influenzae type b tetanus toxoid vaccine (PRP-T) so that infants received a single injection at age 2, 3 and 4 months. One month after the third dose the geometric mean titre of Hib IgG antibody was 0.48 mu g ml(-1). Eighty-two percent of infants achieved a titre of 0.15 mu g ml(-1), with only 27% achieving 1.0 mu g ml(-1) This combination vaccine induced low Hib antibody responses when compared to other studies in which PRP-T was mixed with acellular or whole-cell pertussis vaccines. The combined vaccine did, however, appear to prime a subset of 35 infants for response to a fourth dose of PRP-T at 13 months of age, with a rise in GMT from 0.21 mu g ml(-1) to 36.8 mu g ml(-1). These data have important implications for the introduction of combination acellular pertussis vaccines. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:637 / 642
页数:6
相关论文
共 45 条
[1]  
ANDERSON P, 1984, J INFECT DIS, V149, P1034, DOI 10.1093/infdis/149.6.1034
[2]   HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE-TETANUS PROTEIN CONJUGATE VACCINE DOES NOT DEPRESS SEROLOGIC RESPONSES TO DIPHTHERIA, TETANUS OR PERTUSSIS ANTIGENS WHEN COADMINISTERED IN THE SAME SYRINGE WITH DIPHTHERIA-TETANUS-PERTUSSIS VACCINE AT 2, 4 AND 6 MONTHS OF AGE [J].
AVENDANO, A ;
FERRECCIO, C ;
LAGOS, R ;
HORWITZ, I ;
CAYAZZO, M ;
FRITZELL, B ;
MESCHIEVITZ, C ;
LEVINE, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (08) :638-643
[3]   HAEMOPHILUS-INFLUENZAE TYPE-B CARRIAGE AND IMMUNITY 4 YEARS AFTER RECEIVING THE HAEMOPHILUS-INFLUENZAE OLIGOSACCHARIDE-CRM(197) (HBOC) CONJUGATE VACCINE [J].
BARBOUR, ML ;
BOOY, R ;
CROOK, DWM ;
GRIFFITHS, H ;
CHAPEL, HM ;
MOXON, ER ;
MAYONWHITE, D .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (06) :478-484
[4]   THE IMPACT OF CONJUGATE VACCINE ON CARRIAGE OF HAEMOPHILUS-INFLUENZAE TYPE-B [J].
BARBOUR, ML ;
MAYONWHITE, RT ;
COLES, C ;
CROOK, DWM ;
MOXON, ER .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :93-98
[5]   ANTIBODY-RESPONSES AND SYMPTOMS AFTER DTP AND EITHER TETANUS OR DIPHTHERIA HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES GIVEN FOR PRIMARY IMMUNIZATION BY SEPARATE OR MIXED INJECTION [J].
BEGG, NT ;
MILLER, E ;
FAIRLEY, CK ;
CHAPEL, HM ;
GRIFFITHS, H ;
WAIGHT, PA ;
ASHWORTH, LAE .
VACCINE, 1995, 13 (16) :1547-1550
[6]   Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation [J].
Bell, F ;
Martin, A ;
Blondeau, C ;
Thornton, C ;
Chaplais, J ;
Finn, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (04) :298-303
[7]   Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster [J].
Booy, R ;
Heath, PT ;
Slack, MPE ;
Begg, N ;
Moxon, ER .
LANCET, 1997, 349 (9060) :1197-1202
[8]   IMMUNOGENICITY AND SAFETY OF PRP-T CONJUGATE VACCINE GIVEN ACCORDING TO THE BRITISH ACCELERATED IMMUNIZATION SCHEDULE [J].
BOOY, R ;
TAYLOR, SA ;
DOBSON, SRM ;
ISAACS, D ;
SLEIGHT, G ;
AITKEN, S ;
GRIFFITHS, H ;
CHAPEL, H ;
MAYONWHITE, RT ;
MACFARLANE, JA ;
MOXON, ER .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (04) :475-478
[9]   EFFICACY OF HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINE PRP-T [J].
BOOY, R ;
HODGSON, S ;
CARPENTER, L ;
MAYONWHITE, RT ;
SLACK, MPE ;
MACFARLANE, JA ;
HAWORTH, EA ;
KIDDLE, M ;
SHRIBMAN, S ;
ROBERTS, JSC ;
MOXON, ER .
LANCET, 1994, 344 (8919) :362-366
[10]  
BROWN F, 1997, DEV BIOL STAND, V89, P1